Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan:97:106198.
doi: 10.1016/j.ijsu.2021.106198. Epub 2021 Dec 24.

Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt

Manish Dhawan  1 , Priyanka, Om Prakash Choudhary
Affiliations

Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt

Manish Dhawan et al. Int J Surg. 2022 Jan.
No abstract available

Keywords: B.1.1.529; COVID-19; Emergence; Lessons learnt; Omicron; SARS-CoV-2; Variant of concern.

PubMed Disclaimer

Conflict of interest statement

All authors report no conflicts of interest relevant to this article.

Figures

Fig. 1
Fig. 1
The figure (adapted from www.biorender.com) represents the comparative number of mutations observed in the most dominating variant of the time delta variant and the newly emerged Omicron variant and the potential concerns associated with the emergence of Omicron variant. Moreover, large number of mutations in the Omicron variant can be associated with the increased capability of transmission and the binding affinity with angiotensin converting enzyme 2 (ACE2) receptors to gain access into the host cells. However, there are still several questions marks regarding the concerns related with the Omicron variant such as the actual increase in the transmissibility and virulence which will be addressed in future.
See this image and copyright information in PMC

Comment in

References

    1. Choudhary O.P., Priyanka, Mohammed T.A., Singh I. Intranasal COVID-19 vaccines: is it a boon or bane? Int. J. Surg. 2021;94:106119. doi: 10.1016/j.ijsu.2021.106119. - DOI - PMC - PubMed
    1. Gao S.J., Guo H., Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert. J. Med. Virol. 2021 doi: 10.1002/jmv.27491. - DOI - PMC - PubMed
    1. Karim S.S.A., Karim Q.A. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021 doi: 10.1016/S0140-6736(21)02758-6. - DOI - PMC - PubMed
    1. Gu H., Krishnan P., Ng D.Y.M., Chang L.D.J., Liu G.Y.Z., Cheng S.S.M., Hui M.M.Y., Fan M.C.Y., Wan J.H.L., Lau L.H.K., Cowling B.J., Peiris M., Poon L.L.M. Probable transmission of SARS-CoV-2 Omicron variant in quarantine hotel, Hong Kong, China. Emerg. Infect. Dis. 2021;28(2) doi: 10.3201/eid2802.212422. - DOI - PMC - PubMed
    1. Andrews N., Stowe J., Kirsebom F., Gower C., Ramsay M., Bernal J.L. Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study. medRxiv. 2021 doi: 10.1101/2021.11.15.21266341. 2021.11.15.21266341. - DOI

Supplementary concepts